Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) EV-to-EBITDA : 0.00 (As of Jun. 05, 2024)

Parnell Pharmaceuticals Holdings EV-to-EBITDA Chart

Competitive Comparison of Parnell Pharmaceuticals Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's EV-to-EBITDA falls into.

Parnell Pharmaceuticals Holdings EV-to-EBITDA Calculation

Parnell Pharmaceuticals Holdings's EV-to-EBITDA for today is calculated as:

Parnell Pharmaceuticals Holdings's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Parnell Pharmaceuticals Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2018 was $7.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parnell Pharmaceuticals Holdings  (OTCPK:PARNF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Parnell Pharmaceuticals Holdings's PE Ratio for today is calculated as:

Parnell Pharmaceuticals Holdings's share price for today is $0.0001.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Parnell Pharmaceuticals Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2018 was $0.007.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Parnell Pharmaceuticals Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description